Cell-free biomanufacturing technology is a method for producing biopharmaceuticals and other bioproducts using cell-free systems rather than living cells. In cell-free biomanufacturing, enzymes and other proteins are produced by reconstituting the biochemical machinery of a cell in a cell-free system. This can be done using cell extracts, which are prepared by grinding cells and removing the cell debris, or by synthesizing the proteins de novo using genetic material.
Cell-free biomanufacturing has several advantages over traditional cell-based biomanufacturing. It is faster and more efficient, since it does not require the time-consuming process of growing and culturing cells. It is also more flexible, since it allows for the production of a wider range of proteins and other biomolecules. Additionally, cell-free biomanufacturing is less expensive and requires less infrastructure, making it more suitable for small-scale production.
Cell-free biomanufacturing has potential applications in a wide range of fields, including pharmaceuticals, diagnostics, food and beverage production, and environmental remediation. It has the potential to revolutionize the way that bioproducts are manufactured, making it faster, cheaper, and more efficient to produce a wide range of biomolecules.
Related: EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology
Leave a Reply